Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs

This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.

Detalles Bibliográficos
Autores principales: Shahid, Izza, Khan, Muhammad Shahzeb, Sohail, Aruba, Khan, Safi U., Greene, Stephen J., Fudim, Marat, Michos, Erin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881772/
https://www.ncbi.nlm.nih.gov/pubmed/35212753
http://dx.doi.org/10.1001/jamanetworkopen.2022.0035
_version_ 1784659553371029504
author Shahid, Izza
Khan, Muhammad Shahzeb
Sohail, Aruba
Khan, Safi U.
Greene, Stephen J.
Fudim, Marat
Michos, Erin D.
author_facet Shahid, Izza
Khan, Muhammad Shahzeb
Sohail, Aruba
Khan, Safi U.
Greene, Stephen J.
Fudim, Marat
Michos, Erin D.
author_sort Shahid, Izza
collection PubMed
description This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.
format Online
Article
Text
id pubmed-8881772
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-88817722022-03-04 Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs Shahid, Izza Khan, Muhammad Shahzeb Sohail, Aruba Khan, Safi U. Greene, Stephen J. Fudim, Marat Michos, Erin D. JAMA Netw Open Research Letter This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020. American Medical Association 2022-02-25 /pmc/articles/PMC8881772/ /pubmed/35212753 http://dx.doi.org/10.1001/jamanetworkopen.2022.0035 Text en Copyright 2022 Shahid I et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Shahid, Izza
Khan, Muhammad Shahzeb
Sohail, Aruba
Khan, Safi U.
Greene, Stephen J.
Fudim, Marat
Michos, Erin D.
Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
title Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
title_full Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
title_fullStr Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
title_full_unstemmed Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
title_short Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs
title_sort evaluation of representation of women as authors in pivotal trials supporting us food and drug administration approval of novel cardiovascular drugs
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881772/
https://www.ncbi.nlm.nih.gov/pubmed/35212753
http://dx.doi.org/10.1001/jamanetworkopen.2022.0035
work_keys_str_mv AT shahidizza evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs
AT khanmuhammadshahzeb evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs
AT sohailaruba evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs
AT khansafiu evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs
AT greenestephenj evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs
AT fudimmarat evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs
AT michoserind evaluationofrepresentationofwomenasauthorsinpivotaltrialssupportingusfoodanddrugadministrationapprovalofnovelcardiovasculardrugs

Ejemplares similares